Cargando…
Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial
BACKGROUND: Small fiber neuropathy is the most common cause of neuropathic pain in peripheral neuropathies, with a minimum prevalence of 53/100,000. Patients experience excruciating pain, and currently available anti-neuropathic and other pain drugs do not relieve the pain substantially. Several ope...
Autores principales: | de Greef, Bianca T. A., Geerts, Margot, Hoeijmakers, Janneke G. J., Faber, Catharina G., Merkies, Ingemar S. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955261/ https://www.ncbi.nlm.nih.gov/pubmed/27439408 http://dx.doi.org/10.1186/s13063-016-1450-x |
Ejemplares similares
-
Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy
por: Geerts, Margot, et al.
Publicado: (2021) -
Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Na(v)1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial–the LENSS study
por: de Greef, Bianca T. A., et al.
Publicado: (2016) -
Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects
por: Brouwer, Brigitte A., et al.
Publicado: (2015) -
No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy
por: de Greef, Bianca T. A., et al.
Publicado: (2016) -
Associated conditions in small fiber neuropathy – a large cohort study and review of the literature
por: de Greef, B. T. A., et al.
Publicado: (2017)